Literature DB >> 23397052

Impaired cliff avoidance reaction in dopamine transporter knockout mice.

Motoyasu Yamashita1, Yasufumi Sakakibara, F Scott Hall, Yohtaro Numachi, Sumiko Yoshida, Hideaki Kobayashi, Osamu Uchiumi, George R Uhl, Yoshiyuki Kasahara, Ichiro Sora.   

Abstract

RATIONALE: Impulsivity is a key feature of disorders that include attention-deficit/hyperactivity disorder (ADHD). The cliff avoidance reaction (CAR) assesses maladaptive impulsive rodent behavior. Dopamine transporter knockout (DAT-KO) mice display features of ADHD and are candidates in which to test other impulsive phenotypes.
OBJECTIVES: Impulsivity of DAT-KO mice was assessed in the CAR paradigm. For comparison, attentional deficits were also assessed in prepulse inhibition (PPI) in which DAT-KO mice have been shown to exhibit impaired sensorimotor gating.
RESULTS: DAT-KO mice exhibited a profound CAR impairment compared to wild-type (WT) mice. As expected, DAT-KO mice showed PPI deficits compared to WT mice. Furthermore, the DAT-KO mice with the most impaired CAR exhibited the most severe PPI deficits. Treatment with methylphenidate or nisoxetine ameliorated CAR impairments in DAT-KO mice.
CONCLUSION: These results suggest that DAT-KO mice exhibit impulsive CAR behavior that correlates with their PPI deficits. Blockade of monoamine transporters, especially the norepinephrine transporter (NET) in the prefrontal cortex (PFC), may contribute to pharmacological improvement of impulsivity in these mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23397052     DOI: 10.1007/s00213-013-3009-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

Review 1.  On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy.

Authors:  J T Nigg
Journal:  Psychol Bull       Date:  2000-03       Impact factor: 17.737

2.  Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.

Authors:  M Hiramatsu; A K Cho; T Nabeshima
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

3.  Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1973-06-15       Impact factor: 3.252

4.  Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.

Authors:  Jared W Young; Jordy van Enkhuizen; Catharine A Winstanley; Mark A Geyer
Journal:  J Psychopharmacol       Date:  2011-03-18       Impact factor: 4.153

Review 5.  Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

Authors:  Amy F T Arnsten; Steven R Pliszka
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

6.  Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice.

Authors:  Yosefu Arime; Yoshiyuki Kasahara; F Scott Hall; George R Uhl; Ichiro Sora
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

Review 7.  Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

Authors:  Michael A van der Kooij; Jeffrey C Glennon
Journal:  Neurosci Biobehav Rev       Date:  2007-01-23       Impact factor: 8.989

8.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.

Authors:  R R Gainetdinov; W C Wetsel; S R Jones; E D Levin; M Jaber; M G Caron
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

9.  Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder.

Authors:  Adam R Aron; Jonathon H Dowson; Barbara J Sahakian; Trevor W Robbins
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

10.  Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD).

Authors:  Elise E DeVito; Andrew D Blackwell; Luke Clark; Lindsey Kent; Anna Maria Dezsery; Danielle C Turner; Michael R F Aitken; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2008-09-26       Impact factor: 4.530

View more
  23 in total

1.  Overexpression of the type 1 adenylyl cyclase in the forebrain leads to deficits of behavioral inhibition.

Authors:  Xuanmao Chen; Hong Cao; Amit Saraf; Larry S Zweifel; Daniel R Storm
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

Review 2.  Dopamine transporter mutant animals: a translational perspective.

Authors:  Evgeniya V Efimova; Raul R Gainetdinov; Evgeny A Budygin; Tatyana D Sotnikova
Journal:  J Neurogenet       Date:  2016-03       Impact factor: 1.250

3.  Lack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice.

Authors:  Yudong Gao; Scott A Heldt
Journal:  Behav Neurosci       Date:  2015-02       Impact factor: 1.912

Review 4.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

5.  PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.

Authors:  Tyler Stevens; Katrin Sangkuhl; Jacob T Brown; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2019-08       Impact factor: 2.089

6.  Kdm6b Haploinsufficiency Causes ASD/ADHD-Like Behavioral Deficits in Mice.

Authors:  Yuen Gao; Mohammad B Aljazi; Jin He
Journal:  Front Behav Neurosci       Date:  2022-05-31       Impact factor: 3.617

7.  PI3K signaling in the locus coeruleus: a new molecular pathway for ADHD research.

Authors:  Emmanuel Darcq; Brigitte L Kieffer
Journal:  EMBO Mol Med       Date:  2015-07       Impact factor: 12.137

8.  Abnormal behaviors and developmental disorder of hippocampus in zinc finger protein 521 (ZFP521) mutant mice.

Authors:  Nobutaka Ohkubo; Etsuko Matsubara; Jun Yamanouchi; Rie Akazawa; Mamoru Aoto; Yoji Suzuki; Ikuya Sakai; Takaya Abe; Hiroshi Kiyonari; Seiji Matsuda; Masaki Yasukawa; Noriaki Mitsuda
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

9.  Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety.

Authors:  Yi-Chun Yen; Elmira Anderzhanova; Mirjam Bunck; Julia Schuller; Rainer Landgraf; Carsten T Wotjak
Journal:  Front Behav Neurosci       Date:  2013-08-15       Impact factor: 3.558

Review 10.  Transgenic mouse models for ADHD.

Authors:  Damiana Leo; Raul R Gainetdinov
Journal:  Cell Tissue Res       Date:  2013-05-17       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.